Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
60 participants
INTERVENTIONAL
2017-10-01
2019-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Duloxetine for Acute Post-mastectomy Pain
NCT03468348
Duloxetine and Dexamethasone for Improving Postoperative Pain
NCT03250494
Duloxetine Role in Reducing Opioid Consumption After Thoracotomy
NCT03618225
Combination of Duloxetine and Pregabalin to Improve Postoperative Pain
NCT04862845
Duloxetine vs Pregabalin for Thoracotomy Pain
NCT04782310
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
case group
Duloxetine 60mg orally 12 hours before surgery
Duloxetine 60mg
tablet
Control group
Placebo (glucose powder in a tablet) orally 12 hours before surgery
Placebo
Tablet
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Duloxetine 60mg
tablet
Placebo
Tablet
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient consent
* Patients with ASA class I-II
* Elective gynecological laparoscopy
Exclusion Criteria
* Consuming any pain killers routinely within 48 hours before the surgery
* Smoking, drug abuse
* Patients with major psychiatric disorders, epilepsy or history of convulsion
* Any known kidney or hepatic disorders
* History of any other pervious laparotomy, laparoscopy, or other pelvic manipulation or pathology except normal vaginal delivery
* History of chest or mediastinal surgery or pathology
* Recent flu (six weeks before surgery)
* Suspected to malignancy as pathology
* Those who complained from shoulder pain just before surgery in the first Visual Analog Scale assessment.
20 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
mina fayez ghalyoom
principal invstigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Medicine, Assiut University
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Valadan M, Banifatemi S, Yousefshahi F. Preoperative Gabapentin to Prevent Postoperative Shoulder Pain After Laparoscopic Ovarian Cystectomy: A Randomized Clinical Trial. Anesth Pain Med. 2015 Dec 5;5(6):e31524. doi: 10.5812/aapm.31524. eCollection 2015 Dec.
Study Documents
Access uploaded study-related documents such as protocols, statistical analysis plans, or lay summaries.
Document Type: Clinical Study Report
View DocumentOther Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MFGA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.